Predictive oncology to participate in upcoming investor conferences

Pittsburgh, feb. 21, 2024 (globe newswire) -- predictive oncology inc. (nasdaq: poai), a leader in ai-driven drug discovery and biologics, today announced that raymond f. vennare, chief executive officer, will participate in three upcoming investor conferences. please see below for additional details about the events and how to request a one-on-one meeting with management.
POAI Ratings Summary
POAI Quant Ranking